Crossmark

Computational discovery and experimental verification of tyrosine kinase inhibitor pazopanib for the reversal of memory and cognitive deficits in rat model neurodegeneration

Crossref DOI link: https://doi.org/10.1039/C4SC03416C

Published Online: 2015

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Yang, Yongliang

Li, Guohui

Zhao, Dongyu

Yu, Haoyang

Zheng, Xiliang

Peng, Xiangda

Zhang, Xiaoe

Fu, Ting

Hu, Xiaoqing

Niu, Mingshan

Ji, Xuefei

Zou, Libo

Wang, Jin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (11174105)
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

COPYRIGHT AND LICENSING

: The Royal Society of Chemistry has an exclusive publication licence for this journal

OPEN ACCESS: This article is freely available. This article is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported Licence (CC BY-NC 3.0)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 6 November 2014; Accepted 12 January 2015; Accepted Manuscript published 13 January 2015; Advance Article published 28 January 2015; Version of Record published 20 April 2015

Document is current

Any future updates will be listed below